ctrl K

Watchlist Price Alert

SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

1.88

0.00 (0.16%)

At close: May 14, 2025, 1:31 PM

SAB Biotherapeutics Revenue Breakdown

Period Ending	Dec 31, 2022
Grant Revenue	23.9M
Grant Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Selling, General, and Administrative Revenue	2.47M	3.48M	2.64M	2.23M	13.94M	2.57M	2.9M	3.45M	2.88M	4.04M	4.31M	5.19M	17.09M	335.55K	2.4M	3.33M	9K
Selling, General, and Administrative Revenue Growth	-28.94%	+31.63%	+18.71%	-84.03%	+442.17%	-11.36%	-15.88%	+19.59%	-28.72%	-6.15%	-16.91%	-69.65%	+4991.82%	-86.01%	-28.01%	+36936.53%	n/a
Research and Development Revenue	7.65M	7.83M	6.8M	8.12M	4.3M	4.02M	3.66M	4.54M	7.14M	7.35M	8.58M	13.32M	57.18M	15.07M	18.68M	12.78M	n/a
Research and Development Revenue Growth	-2.29%	+15.15%	-16.30%	+89.05%	+6.91%	+9.76%	-19.26%	-36.46%	-2.92%	-14.35%	-35.57%	-76.70%	+279.45%	-19.34%	+46.17%	n/a	n/a